Middle East & Africa Colorectal Cancer Market Research Report – Segmented By Diagnosis, Treatment & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends and Growth Forecast (2024 to 2029)
MEA Colorectal Cancer Market Size (2023 to 2028)
The Colorectal Cancer Market size in the Middle East & Africa was worth USD 1.73 billion in 2023. This value is estimated to be growing at a CAGR of 2.07% to reach USD 1.92 billion by 2028.
An estimated 5000 people from Saudi Arabia are diagnosing with Cancer every year. Growing health awareness and increasing medical tourism in emerging countries are some of the key factors driving the market in this region.
The surgery treatment associated with colorectal cancer is so expensive. It is not affordable by many of the patients is one of the key factors hampering the market in this region.
This research report on the MEA Colorectal Cancer Market has been segmented and sub-segmented into the following categories:
- By Diagnosis: Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- By Treatment: Surgery And Radiation Therapy, Chemotherapy, Targeted Therapies and Resistance To Pharmacological Therapies
- By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA
Regionally, UAE is considered to lead the colorectal cancer of the MEA region, followed by Saudi Arabia. Other significant markets in this region include Zimbabwe, Zambia, Tanzania, and Nigeria. The market in this region has the lowest share due to the general lack of awareness.
Key market players in MEA Colorectal Cancer Market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, and Vaccinogen BD.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]